Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis
Mingliang Wang, Jing Li, Xiaodong Yang, Qiang Yan, Huizhen Wang, Xin Xu, Yida Lu, Deguan Li, Yi-Gao Wang, Ruochuan Sun, Shangxin Zhang, Yonghong Zhang, Zhen Zhang, Futao Meng, Yongxiang Li
Topics & Concepts
mTORC1Downregulation and upregulationGene knockdownPI3K/AKT/mTOR pathwayUbiquitin ligaseCancer researchUbiquitinChemistryBiologyCell biologySignal transductionBiochemistryGenePI3K/AKT/mTOR signaling in cancerMast cells and histamineHistone Deacetylase Inhibitors Research